PUBLICATION

Chk1 Suppresses a Caspase-2 Apoptotic Response to DNA Damage that Bypasses p53, Bcl-2, and Caspase-3

Authors
Sidi, S., Sanda, T., Kennedy, R.D., Hagen, A.T., Jette, C.A., Hoffmans, R., Pascual, J., Imamura, S., Kishi, S., Amatruda, J.F., Kanki, J.P., Green, D.R., D'Andrea, A.A., and Look, A.T.
ID
ZDB-PUB-080602-16
Date
2008
Source
Cell   133(5): 864-877 (Journal)
Registered Authors
Amatruda, James F., Hagen, Andreas T., Hoffmans, Raymond, Jette, Cicely A., Kanki, John, Kishi, Shuji, Look, A. Thomas, Sidi, Samuel
Keywords
SIGNALING, CELLBIO, CELLCYCLE
MeSH Terms
  • Animals
  • Apoptosis*/drug effects
  • Apoptosis*/radiation effects
  • Caspase 2/metabolism*
  • Caspase 3/metabolism
  • Cell Line, Tumor
  • DNA Damage*
  • Embryo, Nonmammalian/drug effects
  • Embryo, Nonmammalian/metabolism
  • Embryo, Nonmammalian/radiation effects
  • Enzyme Inhibitors/pharmacology
  • Gamma Rays
  • Humans
  • Protein Kinases/metabolism*
  • Proto-Oncogene Proteins c-bcl-2/metabolism
  • Signal Transduction*
  • Tumor Suppressor Protein p53/metabolism
  • Zebrafish/genetics
  • Zebrafish/metabolism*
  • Zebrafish Proteins/metabolism
PubMed
18510930 Full text @ Cell
Abstract
Evasion of DNA damage-induced cell death, via mutation of the p53 tumor suppressor or overexpression of prosurvival Bcl-2 family proteins, is a key step toward malignant transformation and therapeutic resistance. We report that depletion or acute inhibition of checkpoint kinase 1 (Chk1) is sufficient to restore gamma-radiation-induced apoptosis in p53 mutant zebrafish embryos. Surprisingly, caspase-3 is not activated prior to DNA fragmentation, in contrast to classical intrinsic or extrinsic apoptosis. Rather, an alternative apoptotic program is engaged that cell autonomously requires atm (ataxia telangiectasia mutated), atr (ATM and Rad3-related) and caspase-2, and is not affected by p53 loss or overexpression of bcl-2/xl. Similarly, Chk1 inhibitor-treated human tumor cells hyperactivate ATM, ATR, and caspase-2 after gamma-radiation and trigger a caspase-2-dependent apoptotic program that bypasses p53 deficiency and excess Bcl-2. The evolutionarily conserved "Chk1-suppressed" pathway defines a novel apoptotic process, whose responsiveness to Chk1 inhibitors and insensitivity to p53 and BCL2 alterations have important implications for cancer therapy.
Genes / Markers
Figures
Expression
Phenotype
Mutation and Transgenics
Human Disease / Model Data
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping
Errata and Notes